Topics & People

A disease risk associated with the improper dosing of Yamanaka factors.

Adult cells genetically reprogrammed to an embryonic stem cell-like state for creating organoids.

Miniaturized versions of organs produced in vitro for testing drug responses.

Multipotent stem cells used as a delivery mechanism for gene therapies like FOXO3.

A progressive neurodegenerative disease targeted by new mitochondrial therapies.

A neurodegenerative disorder that could potentially be treated by mitochondrial therapy.

A developing therapy aimed at restoring the energy-producing function of cells using young donor mitochondria.

A mental disorder that could be triggered in predisposed individuals by psychedelics.

A severe mental condition that is a potential risk of using high-dose psychedelics.

A test that detects electrical activity in the brain, used to quantify the effects of psychedelics.

Magnetic resonance imaging used to map structural and functional brain changes.

A dissociative anesthetic used as a therapy for depression, previously studied extensively by Kernel.